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Streptococcus pneumoniae serotype 1 is one of the leading causes of invasive pneumococcal disease (IPD) in West Africa, with ST618 
being the dominant cause of IPD in The Gambia. Recently however, a rare example of clonal replacement was observed, where the 
ST3081 clone of serotype 1 replaced the predominant ST618 clone as the main cause of IPD. In the current study, we sought to find 
the reasons for this unusual replacement event. Using whole-genome sequence analysis and clinically relevant models of in vivo 
infection, we identified distinct genetic and phenotypic characteristics of the emerging ST3081 clone. We show that ST3081 is sig-
nificantly more virulent than ST618 in models of invasive pneumonia, and is carried at higher densities than ST618 during nasopha-
ryngeal carriage. We also observe sequence type–specific accessory genes and a unique sequence type–specific fixed mutation in the 
pneumococcal toxin pneumolysin, which is associated with increased hemolytic activity in ST3081 and may contribute to increased 
virulence in this clone. Our study provides evidence that, within the same serotype 1 clonal complex, biological properties differ 
significantly from one clone to another in terms of virulence and host invasiveness, and that these differences may be the result of 
key genetic differences within the genome.
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To date, nearly 100 distinct serotypes of Streptococcus pneumo-
niae (pneumococcus) have been reported [1–7]. In the West 
African subregion as well as globally, pneumococcal serotype 
1 is one of the leading causes of invasive pneumococcal disease 
(IPD) [8–14]. This serotype is known to cause disease out-
breaks, particularly in the African meningitis belt, where the 
serotype 1 ST217 hypervirulent clonal complex has been pre-
dominant [15–20]. An epidemiological review of meningitis 
cases in the African meningitis belt revealed that serotype 1 
was as important as Neisseria meningitidis in its contribution 
to the incidence and mortality caused by bacterial meningitis 
[10]. Despite its strong association with invasive disease, sero-
type 1 is rarely detected during nasopharyngeal carriage. In The 
Gambia, serotype 1 is one of the most common causes of IPD 
responsible for up to 20% of cases, yet is identified in only 0.5% 
of healthy carriers [8, 18, 21, 22]. Compared with other pneu-
mococcal serotypes, serotype 1 has a high odds ratio to cause 
IPD after colonization [23] and is rarely associated with antibi-
otic nonsusceptibility [8, 15, 18]. It has previously been demon-
strated that long-range transmission of serotype 1 is rare, which 
leads to stable circulating clones within geographic regions [24]. 
Newly imported clones have little impact on the epidemiology 
of serotype 1, but we recently reported clonal replacement in 
serotype 1 in The Gambia where the ST3081 clone replaced the 
predominant ST618 as the main cause of IPD [24]. The reasons 
for this were unknown, however.
In the current study, we investigated whether this clonal 
replacement event was a consequence of the presence of vir-
ulence associated genes in the accessory genome of ST3081, 
which were absent in the accessory genome of ST618. To this 
end, we describe the population structure of invasive S. pneu-
moniae serotype 1 isolates collected in The Gambia over a 
20-year period between January 1995 and December 2014, and 
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compare the genomic profiles and in vivo virulence, coloniza-
tion and invasiveness of these 2 important evolving clones.
MATERIALS AND METHODS
Epidemiological Study Design and Collection of Isolates
The study collection included all S. pneumoniae serotype 1 iso-
lates sent to the World Health Organization Regional Reference 
Laboratory for invasive bacterial diseases in the Medical 
Research Council (MRC) Unit of The Gambia, between January 
2004 and December 2014 as part of the routine hospital sur-
veillance for IPD in The Gambia. Samples originated from 
the Western (urban), Central River (rural), and Upper River 
(rural) regions of The Gambia (Supplementary Table S1). We 
also included a previous study collection (1995–2003) of 127 
invasive Gambian isolates [18] and compared these with the 
190 isolates obtained from 2004 to 2014 (Supplementary Table 
S1). Sites of isolation included blood, cerebrospinal fluid, lung 
aspirates, pleural aspirates, or a combination of sites. Twenty-
one pneumococcal carriage isolates (Supplementary Table S1) 
were obtained from a collection of serotype 1 nasopharyngeal 
isolates from healthy individuals in The Gambia, as described 
elsewhere [22]. When >1 isolate was obtained during an illness 
episode, for example from blood and cerebrospinal fluid, only a 
single isolate was included in the study collection, except when 
the isolates differed in multilocus sequence type (MLST) or 
antibiotic susceptibility profile. Isolates were stored in 15% glyc-
erol stocks before study. Isolation of S. pneumoniae and serotyp-
ing by latex agglutination was done as described elsewhere [8]. 
Serotype 1 isolates were confirmed by molecular serotyping, 
also as described elsewhere [25].
Hemolytic Activity Assay
The hemolytic activity of the invasive ST3081 (6308 7#2) and 
ST618 (6309 7#1) isolates was determined using a modified 
version of a previously published method [26]. An extra 6 iso-
lates per sequence type (ST) were tested for confirmation of the 
results. A single colony of each isolate was grown in brain heart 
infusion to a late exponential phase and lysed with 0.1% sodium 
deoxycholate. Approximately 85 µg of total protein was serially 
diluted and incubated with a 4% suspension of sheep red blood 
cells (Oxoid). The suspension was centrifuged after a 30-minute 
incubation at 37°C. The supernatants’ optical density at 540 nm 
was measured to determine the hemolytic activity of each isolate.
In Vivo Models of Nasopharyngeal Carriage and Invasive Pneumonia
All in vivo experiments were done at the University of Liverpool 
under the UK Animals (Scientific Procedures) Act 1986 guide-
lines. The protocols were approved by the UK Home Office 
and by the University of Liverpool Animal Welfare and Ethics 
Committee. All animals were regularly monitored during the 
duration of the experiments and humanely culled at predeter-
mined time points or when they became lethargic. Outbred 
MF1 female mice, 6–8 weeks old (Charles River) were used in 
the study. The animals were left to acclimatize for a minimum of 
7 days before experimentation.
The invasive pneumonia experiments were performed using 
the ST618 (6309 7#1) and ST3081 (6308 7#2) invasive isolates 
while the nasopharyngeal carriage experiments were performed 
using the ST618 (6308 8#18) and ST3081 (6308 8#10) carriage 
isolates. The strains used were representative isolates of each 
ST. Liquid bacterial stocks were used for short term usage by 
growing a sweep of colonies into 20% serum brain heart infu-
sion for approximately 12 hours at 37°C. Stocks were then 
stored at –80°C and viable counts determined using the method 
described by Miles et al [27]. When needed, the bacterial stocks 
were thawed, washed with sterile phosphate-buffered saline 
(PBS), and adjusted to the appropriate density.
Mice were anesthetized with a mixture of oxygen and isoflurane 
(Abbott) and intranasally infected with 106 colony-forming units 
(CFUs) in a 50-µL volume of sterile PBS for the invasive pneumo-
nia model or with 105 CFUs in a 10-µL volume of sterile PBS for 
the nasopharyngeal carriage model, as described elsewhere [28, 
29]. For the nasopharyngeal cocarriage model, mice were intrana-
sally infected with 10 µL of PBS containing 5 × 104 CFUs of ST618 
and 5 × 104 CFUs of ST3081 pneumococci. Blood, lung, brain, and 
nasopharyngeal tissues were collected to determine CFU counts. 
Blood agar plates containing 1  µg/mL of gentamicin were used 
to determine the total number of viable pneumococci; however, 
plates containing 200 µg/mL of streptomycin were used to deter-
mine the number of ST3081 viable counts in the cocarriage exper-
iment. In that case the CFU counts for ST618 were determined 
by subtracting the number of colonies in the streptomycin plates 
from the number of colonies in the gentamicin plates.
Comparative Genomic Analysis
Seventy-four isolates comprising 53 invasive and 21 carriage iso-
lates, ST3081 (n = 38) and ST618 (n = 36), were sequenced at 
the Wellcome Trust Sanger Institute using the Illumina Genome 
Analyzer II (Illumina) (Supplementary Table S2). We used SMALT 
software (version 0.7.4; http://www.sanger.ac.uk/resources/soft-
ware/smalt/) to map the Illumina short read sequences against 
the serotype 1 reference whole-genome sequence SPN1041 
(Genbank No. CACE00000000) to generate the consensus pseu-
dochromosomes for all of the study isolates, which were com-
bined and aligned to generate a whole-genome alignment. All 
nucleotide substitutions were detected using Gubbins software 
(version 1.1.1) [30] and removed to avoid conflicting evolu-
tionary signals when constructing phylogenetic tree of the STs. 
A phylogenetic tree was constructed using RAxML software (ver-
sion 7.0.4) [31]. The following parameters were used for RAxML: 
generalized time-reversible model with gamma heterogeneity 
among nucleotide sites and 100 bootstrap replicates. The phy-
logenetic trees were visualized using FigTree software (http://
tree.bio.ed.ac.uk/software/figtree/) and BioPython scripts [32]. 
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Genome assembly was performed using Velvet (version 1.2.09) 
[33] and SSPACE Basic (version 2.0) [34] software.
We calculated the pairwise nucleotide differences using 
BioPython scripts [32]. Additional evolution parameters; num-
ber of single-nucleotide polymorphism (SNP) sites, number of 
SNPs per nucleotide, observed (π) and expected (Θ) nucleotide 
sequence diversity and Tajima’s D, which is the scaled difference 
between π and Θ, were calculated using MEGA software (ver-
sion 6.0) [35]. To investigate the temporal evolution patterns 
within each ST and to estimate the times to the most recent 
common ancestors or potential emergence of the STs, we used 
Path-O-gen software v1.4 (http://tree.bio.ed.ac.uk/software/
pathogen/).
Data Analysis
To determine the geographic relationship of Gambian serotype 
1 clones to those found in other regions of the world, we per-
formed cluster analysis of allelic profiles of serotype 1 isolates 
fro m this study and from the MLST database, using geoBURST 
software v1.2.1 (http://goeBURST.phyloviz.net). The statistical 
analysis related to the in vivo mouse experiments was carried 
out using the GraphPad Prism statistical package (version 5; 
GraphPad Software). Statistical significance was categorized as 
*P < .05, **P < .01,***P < .005, or ****P < .001.
RESULTS
Multilocus Sequence Typing and Molecular Epidemiology
The majority of pneumococcal serotype 1 isolates were obtained 
between December and June (hot dry season) with peaks at 
the beginning and at the end of the season (Figure 1A). ST618 
was the predominant ST until 2007, when it was replaced by 
ST3081 (Figure 1B). Within 1 year, ST618 was totally replaced 
by ST3081.
Using geoBURST analysis, we showed the existence of a geo-
graphic clustering in the Gambian STs compared with STs iso-
lated from other parts of Africa, from Asia, and from around 
the world (Supplementary Figure S1). Whereas both ST3081 and 
ST618 clustered with clones from Africa and Asia, ST618 was 
positioned between Africa/Asia and the other parts of the world.
In Vivo Characterization of ST618 and ST3081 in Models of Invasive 
Pneumonia
A mouse model of invasive pneumonia was used to compare the 
virulence of ST618 (6309 7#1) and ST3081 (6308 7#2) in vivo. 
Of the mice infected with the ST3081 isolate, 100% developed 
signs of lethargy approximately 24 hours after infection, and all 
succumbed to the infection within 33 hours . In contrast, only 
10% of the mice infected with ST618 died within 33 hours; the 
remaining 90% died within 53 hours (Figure 2), a statistically 
significant difference (P = .03; log-rank [Mantel-Cox] test). 
In time-pointed experiments over 48 hours, mice infected 
with ST3081 pneumococci had significantly higher bacte-
rial loads in the nasopharynx at 12, 24, and 48 hours after 
infection (Figure 3A). Similarly, in the lungs, mice infected 
with ST3081 had significantly higher bacterial loads than 
the ST618-infected mice at 12 and 24 hours after infection, 
with increasing CFU counts at 48 hours (Figure 3B). In 
the brain, no significant differences in CFU counts were 
observed in the first 12 hours after infection, but by 24 
and 48 hours after infection, mice infected with ST3081 
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Figure  1. A, Seasonality in the monthly distribution of invasive serotype 1 
sequence types (STs; ST618, ST3081, and other S1 STs) in Gambia between January 
1995 and December 2014. B, Yearly multilocus ST data of Gambian serotype 1 iso-
lates from 1995 to 2014.
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Figure 2. Survival of mice intranasally infected with 106 colony-forming units of 
ST618 (isolate 6309 7#1) and ST3081 (isolate 6308 7#2; Ten mice infected with 
each isolate). P = .03 (log-rank [Mantel-Cox] test).
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had significantly higher bacterial loads in the brain. 
Interestingly, there were no detectable CFUs for ST618 at 24 
hours, demonstrating a clear difference in systemic tissue 
invasiveness between the 2 isolates (Figure 3C). The same 
pattern was observed in the blood, where ST3081-infected 
mice had significantly higher bacterial CFU counts in blood 
by 12 hours after infection, reaching approximately 107 
CFUs/mL by 24 hours. Once again, ST618 was not detect-
able at either 12 or 24 hours after infection, indicating that 
this ST is less invasive during the first 24 hours of infection 
(Figure 3D). In all experiments, the starting infection inoc-
ulum at time 0 was the same.
In Vivo Characterization of ST3081 and ST618 in Models of 
Nasopharyngeal Carriage
To determine whether ST3081 and ST618 differ in their 
long-term carriage properties, we infected mice with a single 
inoculum of each isolate, separately, and monitored density 
and duration of carriage during the 14  days after infection 
(Figure  4A). ST618 carried in the nasopharynx stably over 
7 days, with a gradual but nonsignificant decline in CFU counts 
by day 14. On the other hand, CFU counts for ST3081 increased 
significantly during the first 7 days after infection. This sharp 
increase in bacterial density peaked at day 7, however, with CFU 
counts dropping significantly by day 14 compared with the pre-
vious 3 time-points. Overall, ST3081 was carried at higher CFU 
counts during the first 7 days, compared with ST618, although 
by day 14 carriage density was the same.
We next sought to assess whether ST3081 had a competitive 
advantage over ST618 to colonize the nasopharynx, by simul-
taneously coadministering mice with the 2 isolates and moni-
toring density and duration of carriage of each respective strain 
over 14 days. Interestingly, when both isolates were coadmin-
istered together, ST618 exhibited an increase in CFU counts 
within the first 24 hours, in contrast to its single-inoculum 
carriage state. However, this increase in bacterial density was 
reduced by day 3 and reached a steady state by day 7 with per-
sistence of carriage maintained thereafter. In contrast, ST3081 
showed a similar carriage profile to its single carriage state over 
the first 3  days after infection, although the peak CFU count 
was at day 3 (compared with day 7 in single-inoculum exper-
iments). Density of carriage showed a steady decline in the 
cocarriage model over time; however, the bacterial density of 
ST3081 remained higher than that of ST618 between days 3 and 
7 after infection (Figure 4B). These observations show that both 
STs follow similar carriage patterns during single colonization 
107
A B
C D
106
* * *† † †
† †
† †
105
104
103
103
102
101
100
C
F
U
s/
m
g 
L
un
g
C
F
U
s/
m
g 
N
as
op
ha
ry
nx
C
F
U
s/
m
g 
B
ra
in
C
F
U
s/
m
L
 B
lo
od
102
101
100
107
108
109
1010
106
105
104
103
102
101
100
0 12
Time, h
24 48
0 12
Time, h
24 48 0 12
Time, h
24 48
0 12
Time, h
24 48
107
106
105
104
103
102
101
100
ST618
ST3081
Figure 3. In vivo characterization of the invasive properties of ST3081 (isolate 6308 7#2; blue triangles) and ST618 (isolate 6309 7#1; red squares). Colony-forming unit 
(CFU) counts are shown for nasopharyngeal (A), lung (B), and brain (C) tissue and for blood (D) during the 48 hours after infection (5 infected mice per time point per isolate). 
*P < .05; †P < .01 (2-way analysis of variance).
Downloaded from https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jix472/4158233
by University of Liverpool user
on 21 November 2017
Comparative Genomic Analysis and In Vivo Modeling of S. pneumoniae ST3081 and ST618 Isolates • JID 2017:XX (XX XXXX) • 5
and cocolonization, with ST3081 able to be carried at a higher 
density than ST618.
Comparative Genomic Analysis
Phylogenetic analysis determined that the ST3081 and ST618 
clones belonged to distinct monophyletic clades separated by 
long branches (Figure 5A). This suggests that ST3081, was not 
a descendant of ST618 but rather emerged as an independent 
clone from a recent introduction of a novel ST217 sublineage in 
The Gambia or as a local clonal expansion of a previously unre-
ported clone. We performed a linear regression analysis of the 
ST-specific phylogenies to determine the correlation between 
the phylogenetic root-to-tip distances and the dates of isolation. 
The time to the most recent common ancestor for ST3081 was 
approximately 2002, which suggests recent introduction into 
The Gambia (Figure  5B), whereas ST618 emerged circa 1917 
(Figure 5C). Both STs show nearly identical nucleotide substi-
tution (mutation) rates, with about 1 SNP introduced annually 
per isolate through spontaneous mutations only rather than 
through genetic recombination.
Significantly higher sequence diversity was observed in ST618 
than in ST3081 (P < .001) (Figure 6A). In ST3081, 13 nucleotides 
distinguished the isolates, whereas this number increased to 93 
nucleotides in ST618. On average, the ST618 isolates showed 
a smaller genome (P < .001) than ST3081, which may suggest 
genome degradation (Figure 6B); however, owing to the short 
sampling period it was not possible to accurately determine 
whether the genome degradation evident in ST618 occurred 
before the strain became endemic. We observed lower average 
pairwise sequence differences (π) than the expected number of 
sites with SNPs (Θ) in ST3081 than in ST618 (Figure 6C).
We performed a core genome analysis of the study strains to 
determine the number of core genes shared by both STs and 
accessory genes that were uniquely associated with a single ST. 
In this study we used an assembly based analysis, in contrast 
to the previously published analysis, which was done using a 
pangenomic mapping of reads approach [24]. Overall, both STs 
shared 1756 core genes, but a total of 120 genes (60 from each 
ST) were associated with a single ST (Figure 5A). In the previ-
ously published study it was found that ST3081 has accessory 
regions containing genes and operons implicated in pneumo-
coccal virulence, such as xerD and the ftsK/spoIIIE operon, that 
are absent in ST618. 
In the current study, the assembly-based approach allowed 
us to identify an additional ST3081 unique gene, murF, which is 
involved in the biosynthesis of peptidoglycan. It has been shown 
in the past that murF impairment can lead to growth arrest and 
autolysis at high temperatures and at low environmental car-
bon dioxide levels [36]. Other uncharacterized ST3081 unique 
accessory genes could also provide a colonization advantage to 
ST3081 over ST618; however, the exact function of these remain 
unknown. In addition, 1 amino acid change in the pneumolysin 
protein which was unique to each ST was observed. At position 
380, all ST3081 isolates contained an asparagine (N) whereas 
all ST618 consisted of an aspartic acid (D) (Figure 5A). The 
presence of asparagine at position 380 in pneumolysin protein 
has previously been associated with increased hemolytic activ-
ity in serotypes that cause outbreaks, suggesting that ST3081 
pneumolysin may have higher hemolytic capacity than ST618 
[26]. This was confirmed by our own hemolytic assays on the 
representative strains used in this study (Figure 7) as well as 
on another 12 strains (6 strains per ST) tested (Supplementary 
Table S3).
DISCUSSION
Identification of the bacterial and host factors that control and reg-
ulate pneumococcal colonization of the nasopharyngeal niche is 
critical to our understanding of transmission events and invasive 
disease. Neill et al [37] have previously highlighted the key role of 
the pneumococcal toxin pneumolysin and the T-regulatory cell–
transforming growth factor β axis in controlling establishment 
and duration of nasopharyngeal carriage [37]. Here, we report 
on the bacterial genetic and phenotypic factors which drive 
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pneumococcal serotype 1 replacement in The Gambia, focusing 
on the capacity of 2 clonal STs to establish colonization in the 
nasopharynx and cause invasive disease.
Using newly acquired genome sequence data, we determined 
the population dynamics of the 2 dominant STs of pneumococ-
cal serotype 1 in The Gambia over a period of 2 decades (Figure 
1B), covering the introduction of 7-valent and 13-valent pneu-
mococcal conjugate vaccine in 2009 and 2011, respectively. 
We show that the emergence of ST3081 was observed before 
the introduction of 7-valent pneumococcal conjugate vaccine 
in 2009, suggesting the absence of any vaccine-driven selec-
tive pressure [38, 39]; and that ST3081 continues to persist as 
the dominant clone since its first detection in 2007, suggesting 
that factors other than vaccine introduction may have caused 
this clonal replacement. We document that the newly dominant 
ST3081 clone occurred in both invasive disease and carriage iso-
lates, and across both rural and urban settings in The Gambia, 
(Supplementary Table S1 and [22]). The same ST3081 clone was 
reported in neighboring Senegal [24], suggesting a possible local 
migration of the strain within the population. We determined 
that ST3081 shared similar characteristics with ST618, includ-
ing being seasonal, occurring mostly during the dry season and 
declining in the rainy season in a fashion similar to meningo-
coccus, a pathogen known to have a high propensity to cause 
epidemic outbreaks.
The current literature describes nasopharyngeal colonization 
as a dynamic process with turnover of new strains or species 
[37, 40]. Using mouse infection models, we sought to compare 
the carriage properties of ST618 and ST3081 and their relative 
propensity to cause invasive disease. We showed that during 
individual colonization events, ST3081 is carried at a higher 
density than ST618 during the first 7 days of carriage, but during 
cocolonization, the carriage density of ST618 is significantly 
increased in the first 24 hours to match ST3081 level; this is a 
transitory event, however, because during the next 6 days CFU 
counts are once again higher for ST3081 than for ST618. In line 
with this finding, results from our mouse invasive pneumonia 
model clearly demonstrate that the newly emerging ST3081 is 
significantly more virulent (and invasive) than the preexisting 
ST618 clone (Figures 2 and 3).
Serotype 1 isolates can be classified into 4 lineages depending 
on their geographic place of isolation [24, 41]. This geographic 
clustering may be due to the short carriage duration of sero-
type 1 strains, resulting in reduced geographic spread of the 
organism [42]. All STs identified in our study belong to the 
ST217 hypervirulent clonal complex responsible for epidemic 
outbreaks across the African meningitis belt [18, 20]. ST3081 
is a single-locus variant of ST217 and quadruple-locus variant 
of ST618. To assess whether genetic recombination or point 
mutations explain the emergence of ST3081 [43, 44], we used 
whole-genome sequencing to determine the genomic differ-
ences between these 2 STs. Our results showed that ST3081 
isolates exhibited lower sequence diversity than ST618 isolates, 
most likely a consequence of its recent emergence (in about 
2002).The lower diversity in the ST3081 may be a consequence 
of a transmission bottleneck, which subsequently resulted in a 
lower population size, rather than the effect of negative selec-
tion. Further analysis of the distribution of SNPs in the 2 STs 
suggests that the population size of ST3081 is smaller than that 
of ST618 but is slowly expanding over time.
We also found that the murF gene, which is involved in the 
biosynthesis of peptidoglycan, is present in ST3081 isolates but 
absent in ST618 isolates. This is a significant finding, because 
impairment of this gene has previously been associated with 
inhibited growth and autolysis at certain environmental condi-
tions, such as high temperatures and low environmental carbon 
dioxide levels, suggesting that ST3081 might be better adapted 
at surviving at high temperature conditions than ST618 and 
may therefore have a fitness advantage over ST618 [36]. This 
ST-specific gene, together with other uncharacterized genes, 
may contribute to differences in virulence between the STs. 
In addition, we found a single amino acid change in the 
pneumolysin toxin in ST3081 compared with ST618; this 
particular amino acid change has previously been associated 
with increased hemolysis in serotypes causing outbreaks [26]. 
Indeed, we showed that ST3081 has higher hemolytic activity 
than ST618 in vitro. Multiple studies have shown the impor-
tance of pneumolysin and its hemolytic activity in the virulence 
of the pneumococcus. Pneumolysin-deficient pneumococci 
have significantly lower ability to colonize the nasopharynx 
of mice, leading to reduced colonization density and shorter 
duration of colonization; they are also less able to cause invasive 
disease in mice, leading to prolonged survival compared with 
that in mice infected with pneumolysin-producing pneumo-
cocci [45–49]. The pneumolysin hemolytic activity–increasing 
amino acid change observed in ST3081 would hence increase 
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virulence and tissue invasiveness, potentially allowing this ST 
to become the dominant ST in Gambia.
In the current study, we provided in vivo and genomic evi-
dence that, within a given serotype, clonal properties may vary 
significantly and are an important determinant in the ability 
of pneumococcal clones to compete with each other, colonize 
the nasopharynx, and cause invasive disease. Our study high-
lights the importance of continuing surveillance to monitor the 
emergence of potentially more virulent and invasive pneumo-
coccal clones and provides evidence addressing the intriguing 
question of whether clonal replacement is the result of naturally 
occurring competitive interactions within the host or the con-
sequence of environmental and host influences.
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